Redwood City, CA, United States of America

James R Kerr

This inventor holds 1 USPTO granted patent. Top assignee: Incyte Pharmaceuticals, Inc.. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 69(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: James R Kerr: Innovator in Biomolecular Expression Information Processing

Introduction

James R Kerr is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of biomolecular expression information processing. His innovative work has led to the development of a unique system that enhances the analysis and storage of expression datasets.

Latest Patents

James R Kerr holds a patent for a "System and method for generating, analyzing and storing normalized expression datasets from raw expression datasets derived from microarray includes nucleic acid probe sequences." This patent describes a biomolecular expression information processing system that includes procedures and tables for storing abundance datasets and hybridization data. The system is designed to identify microarray technology types and includes detailed microarray design information. This innovation allows for the processing of abundance datasets in accordance with the associated microarray design information.

Career Highlights

James R Kerr is currently employed at Incyte Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at Incyte has positioned him as a key player in the field of biomolecular research.

Collaborations

Throughout his career, James has collaborated with notable colleagues, including Jeffrey J Seilhamer and Timothy J Maslyn. These collaborations have further enriched his contributions to the field.

Conclusion

James R Kerr's innovative work in biomolecular expression information processing has made a significant impact in the field. His patent and ongoing research at Incyte Pharmaceuticals, Inc. highlight his dedication to advancing scientific knowledge and technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…